[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625369":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":45,"collaborators":47,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":54,"acronym":10,"eligibilityCriteria":55,"healthyVolunteers":52,"sex":56,"minAge":10,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":67,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Aura Biosciences","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"No Intervention",null,"Observational",[13],"Other: Non-interventional, digital, patient-reported, real-world study",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"OTHER","Non-interventional, digital, patient-reported, real-world study","Surveys will be collected at the following key timepoints:\n\nScheduled visits:\n\nVisit 2\\_Cycle 1\\_Day 1 Visit 8 (week 4, Day 29) Visit 19 (24-hr f\u002Fy +\u002F- 4hrs last tx) Visit 20 (week 12, day 84) Visit 22 (week 20, day 84) Visit 25 (week 52, day 364) Visit 26 (week 65, day 455) Visit 27 (week 78, day 546) Visit 28 (week 91, day 637) Visit 29 (week 104, day 728) End of Trial or Early Termination",[9],[21],{"name":22,"affiliation":5,"role":23},"Study Director","STUDY_DIRECTOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Medical Monitor","CONTACT","617-500-8864","clinical@aurabiosciences.com",[31],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":10},"Eye Research Australia","RECRUITING","East Melbourne","Victoria","3002","Australia","AU",{"type":40,"coordinates":41},"Point",[42,43],144.9879,-37.81667,{"lat":43,"lon":42},{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[48],{"name":49,"class":6},"Vitaccess Ltd","100625369","choroidal-melanoma-patient-reported-outcome-study-cm-pro-in-a-subset-of-au-011-301-compass-subjects-100625369",false,"NCT07421739","Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects","Inclusion Criteria:\n\n* Have enrolled in the Aura-sponsored clinical trial AU-011-301.\n* Access to a connected device (i.e., smartphone, laptop, or tablet)\n\nExclusion Criteria:\n\n* None","ALL",{"count":58,"type":59},15,"ESTIMATED","OBSERVATIONAL","To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.",[63,64,65,66],"Choroidal Melanoma","Indeterminate Lesions","Uveal Melanoma","Ocular Melanoma",[65,68,66,63],"Eye Cancer","2026-02-17",{"date":71,"type":72},"2026-02-19","ACTUAL",{"date":74,"type":72},"2025-11-12",{"date":76,"type":59},"2028-08-15",{"name":5,"class":6},1]